TrademarkDir
PUREMIDINE
LIVE

Serial Number

97096288

Owner

Oxford Healthspan LLC

Attorney

KEVIN M HAYES

Filing Date

Oct 27, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PUREMIDINE Trademark

Serial Number: 97096288

PUREMIDINE is a trademark filed by Oxford Healthspan LLC on October 27, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Oxford Healthspan LLC (3 trademarks)

1309 Coffeen Ave., Suite 1547
Sheridan, WY 82801

Entity Type: 16

Trademark Details

Filing Date

October 27, 2021

Registration Date

Not Registered

Goods & Services

Nutritional supplements for pets

Filing History

REPLY BRIEF FILED - CHECK TTAB FILES
Mar 3, 2026 RBFT
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Feb 9, 2026 GNSN
EXAMINERS STATEMENT E-MAILED
Feb 9, 2026 GNES
EXAMINERS STATEMENT - COMPLETED
Feb 9, 2026 CNES
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 9, 2025 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Oct 7, 2025 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Oct 7, 2025 GECD
ACTION CONTINUING FINAL - COMPLETED
Oct 7, 2025 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2025 CRFA
ASSIGNED TO LIE
Aug 27, 2025 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 18, 2025 ERFR
EX PARTE APPEAL-INSTITUTED
Aug 18, 2025 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 18, 2025 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Aug 18, 2025 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 13, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 13, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 19, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 19, 2025 GNFR
FINAL REFUSAL WRITTEN
Feb 19, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 2, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 26, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 26, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 30, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 30, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 30, 2024 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 12, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 12, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 22, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 8, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 8, 2022 GNSL
SUSPENSION LETTER WRITTEN
Aug 8, 2022 CNSL
ASSIGNED TO EXAMINER
Aug 3, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2021 NWOS
NEW APPLICATION ENTERED
Oct 30, 2021 NWAP

Related Trademarks

More from this Owner

OXFORD HEALTHSPAN

OXFORD HEALTHSPAN

OXFORD HEALTHSPAN

OXFORD HEALTHSPAN

OXFORD HEALTHSPAN

OXFORD HEALTHSPAN

PRIMEADINE

PRIMEADINE

PRIMEADINE

PRIMEADINE

PRIMEADINE

PRIMEADINE